Lisa Kim, Forbes Staff

Author's posts

Biden Receives Second Booster Shot And Calls On Congress To Pass Emergency Covid Funding

The FDA on Tuesday authorized Moderna’s and Pfizer-BioNTech’s Covid-19 vaccine second booster doses for people 50 and older.

Billionaire Mark Cuban Opens Online Pharmacy To Provide Affordable Generic Drugs

The company was launched out of stealth last year.

Pfizer Says Its Covid Antiviral Pill Is Effective Against Omicron Variant

Last month, Pfizer reported its coronavirus antiviral drug is 89% effective at stopping hospitalizations and deaths in high-risk Covid-19 patients.

Dogs Can Sniff Out Long Covid-19, French Study Suggests

Three school districts in Massachusetts are using trained dogs to detect the coronavirus in classrooms.

United Cuts Flights After About 3,000 Workers Test Positive For Covid-19

None of its vaccinated employees are hospitalized for Covid, CEO Scott Kirby says.

These 18 States Are Grappling With Critical Hospital Worker Shortages As Covid Hospitalizations Surge

Hospitalizations due to Covid-19 are soaring across the country at the same time that a growing number hospitals are struggling with depleted numbers of doctors, nurses and other workers.

Scientists Identify Coronavirus Strain In Cyprus—‘Deltacron’—That Blends Delta And Omicron

A total of 25 cases of a strain dubbed “deltacron” have been found in that country.

Covid Booster Shot Increases Vaccine Effectiveness To 71%-75% Against Omicron, U.K. Scientists Say

The omicron variant is expected to make up more than half of all Covid cases in the U.K. by mid-December, the agency said.

EU Drug Regulator Backs Emergency Use Of Merck’s Covid Antiviral Pill

The regulator said earlier that it is expected to finalize its authorization of the drug by the end of this year.

U.S. Reportedly Buying 10 Million Courses Of Pfizer Antiviral Pills

Pfizer has said its drug to treat Covid-19 reduced the risk of hospitalization or death due to the disease by 89% compared to a placebo.